Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Netflix
NFLX
|
+$721M |
| 3 |
Apple
AAPL
|
+$468M |
| 4 |
UnitedHealth
UNH
|
+$422M |
| 5 |
GE Vernova
GEV
|
+$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$673M |
| 2 |
Robinhood
HOOD
|
+$481M |
| 3 |
Meta Platforms (Facebook)
META
|
+$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$402M |
| 5 |
Palantir
PLTR
|
+$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Keros Therapeutics
KROS
$636M
| $1.96M | ﹤0.01% |
+146,600
| New | +$1.96M |
|
2127
Agilon Health
AGL
$443M
| $1.96M | ﹤0.01% |
850,000
-441,000
| -34% | -$1.01M |
|
2128
Editas Medicine
EDIT
$242M
| $1.95M | ﹤0.01% |
888,400
-144,565
| -14% | -$318K |
|
2129
Semtech
SMTC
$5.23B
| $1.95M | ﹤0.01% |
43,216
+30,200
| +232% | +$1.36M |
|
2130
Assembly Biosciences
ASMB
$168M
| $1.95M | ﹤0.01% |
107,521
-5,790
| -5% | -$105K |
|
|
EFXT
2131
Enerflex
EFXT
$1.29B
| $1.94M | ﹤0.01% |
246,300
+32,700
| +15% | +$258K |
|
2132
HUTCHMED
HCM
$3.08B
| $1.94M | ﹤0.01% |
129,000
-6,200
| -5% | -$93.3K |
|
2133
AXIS Capital
AXS
$7.75B
| $1.94M | ﹤0.01% |
18,700
-20,000
| -52% | -$2.08M |
|
2134
iShares Core MSCI Total International Stock ETF
IXUS
$49B
| $1.94M | ﹤0.01% |
25,100
+300
| +1% | +$23.2K |
|
2135
Lightpath Technologies
LPTH
$236M
| $1.94M | ﹤0.01% |
629,347
-20,998
| -3% | -$64.7K |
|
2136
Integral Ad Science
IAS
$1.4B
| $1.93M | ﹤0.01% |
232,300
-207,700
| -47% | -$1.73M |
|
2137
Zumiez
ZUMZ
$347M
| $1.92M | ﹤0.01% |
144,900
+14,900
| +11% | +$198K |
|
2138
Maui Land & Pineapple Co
MLP
$370M
| $1.92M | ﹤0.01% |
105,549
+900
| +0.9% | +$16.4K |
|
2139
Eagle Bancorp
EGBN
$615M
| $1.9M | ﹤0.01% |
97,680
+39,980
| +69% | +$779K |
|
2140
Liberty Live Group Series A
LLYVA
$8.95B
| $1.9M | ﹤0.01% |
23,900
-39,200
| -62% | -$3.12M |
|
2141
Five Star Bancorp
FSBC
$701M
| $1.9M | ﹤0.01% |
66,500
-8,700
| -12% | -$248K |
|
2142
Village Farms International
VFF
$297M
| $1.89M | ﹤0.01% |
1,722,066
+759,013
| +79% | +$835K |
|
2143
Chesapeake Utilities
CPK
$2.95B
| $1.89M | ﹤0.01% |
+15,750
| New | +$1.89M |
|
2144
Laird Superfood
LSF
$61.3M
| $1.89M | ﹤0.01% |
300,500
+25,200
| +9% | +$159K |
|
2145
Granite Construction
GVA
$4.7B
| $1.89M | ﹤0.01% |
20,200
-3,700
| -15% | -$346K |
|
2146
Allogene Therapeutics
ALLO
$251M
| $1.89M | ﹤0.01% |
1,670,012
+113,312
| +7% | +$128K |
|
|
INZY
2147
DELISTED
Inozyme Pharma
INZY
| $1.88M | ﹤0.01% |
470,500
-93,954
| -17% | -$376K |
|
2148
Sight Sciences
SGHT
$181M
| $1.88M | ﹤0.01% |
455,026
-152,251
| -25% | -$629K |
|
2149
CorMedix
CRMD
$966M
| $1.88M | ﹤0.01% |
+152,200
| New | +$1.88M |
|
2150
Flexible Solutions
FSI
$123M
| $1.87M | ﹤0.01% |
386,442
-4,203
| -1% | -$20.4K |
|